Newsletter

The True "Black Swan" Event

COVID-19 doesn't qualify, but our vulnerability is another matter entirely

Budgeting Around COVID-19

Uncertainty reigns, making budgeting for next year something quite different

Business Models — Bounce or Break

Recurring revenues will prove more resilient, while Gold OA may prove frangible

Ten Changes COVID-19 May Bring

Changes in taxation, real estate, education, wages, benefits, and prices are all possible

Don't Ask, Don't Tell at medRxiv

A preprint shouldn't have been accepted by a journal — but they don't ask

Did medRxiv Get Played?

A company appears to have used the preprint server to drive sales — without a preprint

Coronavirus Preprints in medRxiv

Dominating recent weeks, few are published in journals, and some break the rules

The Private Data Game & Public Health

Is the feverish pace of data gathering driving some companies to avoid legitimate outlets?

An Abundance of Caution

Preprints disclaiming lack of peer review aren't telling the whole story

The Costs of Canceled Meetings

Some societies are vulnerable to the lost revenues, while others can absorb the blow